Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

SYM S011 - Update Platform: Cutaneous Oncology

Open admission to eligible categories, no tuition or ticket


Date: Saturday, August 03

CME Credits: 2.00

Location: Grand Ballroom East

Time: 2:00 PM - 4:00 PM

Director: Fiona O'Reilly Zwald, MD, FAAD


  • Scott W. Fosko, MD, FAAD
  • Allison Hanlon, MD, PhD, FAAD
  • Chrysalyne Delling Schmults, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Identify the relevant molecular and cellular interactions that affect the pathogenesis of malignant melanoma, non-melanoma skin cancer, Merkel cell carcinoma and cutaneous lymphoma.
  • Describe the changing role of the pathologist and potential utilization of biomarker assessment in the staging and management of patients with malignant melanoma.
  • Recognize the advantages and disadvantages of the most recent therapeutic advances in the medical management of cutaneous malignancies.

The purpose of this platform session is to provide attendees with updates on important news and research in cutaneous oncology that increase our understanding of disease mechanisms and their implications for therapy.


Saturday, August 03
2:00 PMIntroduction / Dr. Zwald
2:00 PMVismodegib for BCC and Imiquimod for Lentigo maligna: an update / Dr. Fosko
2:30 PMUpdate on unusual tumors / Dr. Hanlon
3:00 PMUpdate on SCC staging: Defining high-risk SCC / Dr. Schmults
3:30 PMManagement of high risk SCC in transplant patients; an update / Dr. Zwald